Septerna (SEPN) Retained Earnings (2023 - 2026)
Septerna's (SEPN) quarterly Retained Earnings came in at -$175.9 million in Q1 2026, down 88933.33% year-on-year from N/an in Q1 2025, and down 28607.29% quarter-over-quarter from $617000.0 in Q4 2025.
Septerna (SEPN) Retained Earnings (2023 - 2026) Analysis & Trends
Septerna's Retained Earnings history runs 4 years deep, the most recent figure standing at -$175.9 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 88933.33% year-over-year to -$175.9 million in Q1 2026; TTM through Mar 2026 was -$175.9 million, a 88933.33% decrease from a year earlier, with the FY2025 full-year figure at $617000.0, up 1001.79% from the prior year.
- Retained Earnings slipped to -$175.9 million in Q1 2026 per SEPN's latest filing, from $617000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $617000.0 in Q4 2025 and bottomed at -$175.9 million in Q1 2026.
- The 4-year median for Retained Earnings is -$23.3 million (2023), against an average of -$67.8 million.
- Biggest YoY gain for Retained Earnings was 1001.79% in 2025; the steepest drop was 89028.98% in 2025.
- Year by year, Retained Earnings stood at -$46.6 million in 2023, then jumped by 100.12% to $56000.0 in 2024, then soared by 1001.79% to $617000.0 in 2025, then sank by 28607.29% to -$175.9 million in 2026.
- Per Business Quant, the three latest SEPN Retained Earnings figures stand at -$175.9 million (Q1 2026), $617000.0 (Q4 2025), and -$156.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | -175.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -175.89 Mn |
| Dec 31, 2025 | 617,000.00 |
| Sep 30, 2025 | -156.52 Mn |
| Jun 30, 2025 | -164.70 Mn |
| Mar 31, 2025 | 198,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 176,000.00 |
| Dec 31, 2023 | -46.58 Mn |